CAMLINFINE quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Camlin Fine Sciences Ltd reported sales of ₹491 Cr, operating profit of ₹2 Cr (OPM 0.5%) and net profit of ₹-30 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
CAMLINFINE quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
431
432
408
450
441
425
520
491
YoY Sales growth
12
15
7
8
2
-2
28
9
Expenses
375
370
387
415
420
404
511
489
Operating Profit
56
62
20
35
21
21
9
2
OPM
13%
14%
5%
8%
4.7%
5%
1.8%
0.5%
Other Income
-8
-22
0
-9
-24
103
-10
2
Interest
34
15
15
18
17
23
14
21
Depreciation
14
17
16
18
16
21
19
20
Profit before tax
0
8
-11
-9
-37
80
-34
-37
Tax
2,164%
98%
0%
65%
0%
-8%
-1%
-19%
Net Profit
-7
0
-11
-15
-37
86
-34
-30
EPS in Rs
-0.24
-0.04
-0.53
-0.76
-1.89
4.59
-1.65
-1.45
CAMLINFINE profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
1,412
1,682
1,454
1,629
1,723
1,877
Sales growth
19
19
-14
12
6
9
Expenses
1,254
1,471
1,284
1,402
1,605
1,823
Operating Profit
158
211
170
227
118
54
OPM
11%
13%
12%
14%
7%
2.9%
Other Income
33
-4
-142
-218
59
70
Interest
41
64
70
107
83
75
Depreciation
56
63
56
61
71
76
Profit before tax
94
80
-99
-159
23
-28
Tax
36%
50%
6%
0%
-2%
-
Net Profit
60
40
-105
-158
24
-14
EPS in Rs
3.78
3.24
-5.41
-7.4
1.44
-0.4
Dividend Payout
0%
0%
0%
0%
0%
-
CAMLINFINE balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
16
17
19
19
19
Reserves
804
848
883
871
1,022
Borrowings
801
683
652
672
720
Other Liabilities
425
424
467
476
559
Total Liabilities
2,045
1,972
2,020
2,037
2,320
Fixed Assets
858
816
704
700
887
CWIP
43
46
10
15
33
Investments
8
8
61
69
30
Other Assets
1,136
1,102
1,246
1,253
1,370
Total Assets
2,045
1,972
2,020
2,037
2,320
CAMLINFINE cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
145
51
139
23
82
Cash from Investing Activity
-249
-125
-66
-75
-53
Cash from Financing Activity
136
60
-86
76
-25
Net Cash Flow
32
-14
-13
24
4
Free Cash Flow
-68
-93
79
-19
20
CFO/OP
111%
34%
110%
27%
90%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit